Abstract
<p class="abstract"><strong><span lang="EN-US">Background:</span></strong><span lang="EN-US"> Treatment of gastrointestinal symptoms in patients with systemic sclerosis has been a challenge for years. Drugs, immunosuppressive or anti-fibrotic have always been associated with complications. The effectiveness of probiotics as live microorganisms of nonpathogenic always was to treat the symptoms.</span></p><p class="abstract"><strong><span lang="EN-US">Methods:</span></strong>In this clinical trial, 37 patients with systemic sclerosis with mild to severe symptoms in the intervention and control groups were studied. Inventory (UCLA SCTC GIT 2.0) was used for rating the severity of the gastrointestinal tract. Collected data was analysed by statistical methods using SPSS.19.</p><p class="abstract"><strong><span lang="EN-US">Results:</span></strong><span lang="EN-US"> Improvement was seen in total score after the use of probiotics in gastrointestinal reflux condition ((P=0.001), gastric distention (P =0.001), emotional function ((P=0.001), social.</span></p><p class="abstract"><strong><span lang="EN-US">Conclusions:</span></strong>This study showed that probiotics were significantly effective in treatment of gastrointestinal symptoms in patients with <span lang="EN-US">systemic sclerosis.</span></p>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
